Lapatinib or Trastuzumab? Which Anti-Her2 Treatment is More Effective in the Treatment of Patients with Her2-Positive Breast Cancer with Brain Metastases? An Anatolian Society of Medical Oncology Study için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Lapatinib or Trastuzumab? Which Anti-Her2 Treatment is More Effective in the Treatment of Patients with Her2-Positive Breast Cancer with Brain Metastases? An Anatolian Society of Medical Oncology Study | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Aralık 2024 | 0 |
| Ocak 2025 | 0 |
| Şubat 2025 | 0 |
| Mart 2025 | 0 |
| Nisan 2025 | 0 |
| Mayıs 2025 | 0 |
| Haziran 2025 | 0 |
